CytoMed Therapeutics Limited (GDTC) Revenue 2024–2025
CytoMed Therapeutics Limited (GDTC) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$252,265FY2025 · since FY2024: $50,872 → $252,265
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $252,265 | +395.9% |
| FY2024 | $50,872 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GDTC financial trends
GDTC Net incomeGDTC Net marginGDTC Gross profitGDTC Gross marginGDTC Operating incomeGDTC Operating marginGDTC Operating cash flowGDTC Free cash flowGDTC Capital expendituresGDTC Return on equityGDTC Stock buybacksGDTC Dividends paidGDTC Total assetsGDTC Total liabilitiesGDTC Shareholders’ equityGDTC overview →